Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma

Modern Pathology

Volumn 9, Issue 8, 1996, Pages 854-860

  Ross, Jeffrey S ^a   Del Rosario, Arthur D ^b   Bui, Hai X ^a   Kallakury, Bhaskar V S ^a   Okby, Nader T ^a   Figge, James ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bladder; CD44; Cell carcinoma; DNA ploidy; Transitional

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; UVOMORULIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; ANTIGENS, CD44; CARCINOMA, TRANSITIONAL CELL; DNA, NEOPLASM; FEMALE; HUMANS; IMAGE CYTOMETRY; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 0029739259     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Brown TA, Bouchard T, St. John T, Wayner E, Carter WG: Human keratinocytes express a new CD44 core protein (CD44e) as a heparin-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113:207, 1991
2. Haynes BF, Telen MJ, Hale LP, Denning SM: CD44-A molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:424, 1989
3. Lesley J, Hyman R, Kincaid PVV: CD44 and its interaction with extra cellular matrix. Adv Immunol 54:271, 1993
4. Screaton GR, Bell MV, Jackson DG, et al: Genomic structure of DNA in coding the lymphocyte homing receptor CD44 reveals at least twelve alternatively spliced exons. Proc Natl Acad Sei U S A 89:12160, 1992
5. Jalkanen S, Bargatzi RF, de los Toyos J, Butcher EC: Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen to differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105:983, 1987
6. Picker LJ, Nakache M, Butcher EC: Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules in diverse cell types. J Cell Biol 109:927, 1989
7. Stamenkovic I, Amiot M, Pesando LM, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057, 1989
8. Aruffo A, Stamenkovic I, Melnick M, Underbill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990
9. Jalkanen S, Bargotsi RF, Herron LR, Butcher AC: A lymphoid cell surface protein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16:1195, 1986
10. Kalomiris EL, Bourguignon LYW: Mouse T lymphoma cells contain a transmembrane glycoprotein (gp 85) that binds ankyrin. J Cell Biol 106:319, 1988
11. Wayner EA, Carter WG: Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol 105:1873, 1987
12. St. John T, Meyer J, Idzera R, Gallatin WM: Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60:45, 1990
13. Carter WG, Wayner EA: Characterization of a collagen-bind-ing, phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263:4193, 1988
14. Gunthert U, Hofmann M, Rudy W, et al: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
15. Rudy VV, Hofmann M, Schwartz-Albiez R, et al: The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different spliced variants: Each one individually suffices to confirm metastatic behavior. Cancer Res 53:1262, 1993
16. Hofmann M, Rudy W, Zoller M, et al: CD44 splice variants confirm metastatic behavior in rats: Analogous sequences are expressed in human tumor cell lines. Cancer Res 51:5292, 1991
17. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053, 1992
18. Jalkanen S, Joensuu H, Soderstrom KO, Klemi PJ: Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest 87:1835, 1991
19. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S: Glycoprotein / CD44 expression and its association with survival in breast ' cancer. Am J Pathol 143:867, 1993
20. Washington MK, Gottfried MR, Telen MJ: Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas (abstract). Lab Invest 68:52A, 1993
21. Figge J, del Rosario AD, Gerasimov G, et al.: Preferential expression of the cell adhesion molecule in papillary thyroid carcinoma. Exp Mol Pathol 61:203, 1994
22. Ross JS, del Rosario AD, Sanderson B, Bui HX: Selective expression of CD44 cell adhesion molecule in thyroid papillary carcinoma fine needle aspirates. Diagn Cytopathol 1996 (in press)
23. Moshaluk CA, Hamilton SR: Expression of CD44 in Barren's esophagus and associated neoplasms (abstract). Mod Pathol 7:65A, 1994
24. Penno MB, August JT, Baylin SB, et al: Expression of CD44 in human lung tumors. Cancer Res 54:1381, 1994
25. Herrlich P, Zoller M, Pals ST, Ponta H: CD44 splice variants: Métastases meet lymphocytes. Immunol Today 14:395, 1993 /26. Tanabe KK, Ellis LM, Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and métastases. Lancet 341:725, 1993
26. Harn HJ, Leeh S, Ho U, Yu CP, Lee WH: The variant mRNA isoform of human métastases gene (CD44V) detected in the cell lines of human hepatocellular carcinoma. Biochem Mol Biol Int 32:233, 1994
27. Harn HJ, Leeh S, Ho LI, Yu CP, Lee WH: Selective expression of CD44 messenger RNA splice variance in four grade human brain tumor cell lines. Biochem Mol Biol Int 33:742, 1994
28. Heider KH, Dammrich J, Skroch-Angel P, et al: Differential expression of CD44 splice variants in intestinal and diffuse type human gastric carcinomas and normal gastric mucosa. Cancer Res 53:4197, 1993
29. Harn HJ, Lee IH, Chang JY, et al: Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects. Cancer 75:1065, 1995
30. Koss LG: Tumors of the urinary bladder. In Atlas of Tumor Pathology, Fascicle 11. Washington, DC, Armed Forces Institute of Pathology, 1975
31. Marshall VF: The relation of the pre-operative estimate to the pathologic demonstration of the extent of vesicle neoplasms. J Urol 68:714, 1952
32. Bacus JW, Bacus JV: A method of correcting DNA ploidy measurements in tissue sections. Mod Pathol 7:652, 1994
33. Ross JS, del Rosario AD, Figge HL, et al: E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder. Hum Pathol 26:940, 1995
34. Whitmore VF Jr: Bladder cancer: An overview. Cancer J Clin 38:13, 1988
35. Raghaven D, Shipley W, Garnick MD, et al: Biology and management of bladder cancer. N Engl J Med 322:1129,1990
36. Lopez-Beltran A, Croghan GA, Croghan I, et al: Prognostic factors in survival of bladder cancer. Cancer 70:799, 1992
37. Albelda SM: Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68:4, 1993
38. Bringuier PP, Umbas R, Schaafsma AG, et al: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53:3241, 1993
39. Ross JS: DNA ploidy and cell cycle analysis in pathology. New York, Igaku-Shoin, p 78, 1995
40. Kallakury BVS, Figge J, Yang F, et al: Down-regulation of CD44 protein and mRNA in prostate cancer: Correlation with tumor grade and ploidy (abstract). Mod Pathol 75A, 1996.